My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Bayer to acquire Monsanto in all cash transaction

Bayer to acquire Monsanto in all cash transaction

Sep 14,2016

Monsanto India announced that Bayer and Monsanto signed definitive agreement under which Bayer will acquire Monsanto for USD 128 per share in an all cash transaction.

Powered by Capital Market - Live News

Nikkei extends gain on softer yen
Nov 11,2016

The Japan share market inclined for second straight session on Friday, 11 November 2016, supported by yen depreciation to mid 106-level against greenback and hopes Trump administration will boost spending and spur U.S. economic growth. 18 out of 33 TSE industry categories closed in positive territory, led by Insurance, Banks, Nonferrous Metals, Securities & Commodities Futures, and Iron & Steel stocks, while Information & Communication, Fishery, Agriculture & Forestry, Retail Trade, and Electric Power & Gas were notable losers. The 225-issue Nikkei Stock Average rose 30.37 points, or 0.18%, to 17,374.79, while the broader Topix index of all First Section issues on the Tokyo Stock Exchange jumped 1.93 points, or 0.14%, to end at 1,378.28.

Powered by Capital Market - Live News

Australia Stocks incline for second straight day
Nov 11,2016

Australian share market inclined for second successive session on Friday, 11 November 2016, on the back positive lead from Wall Street overnight and jump in commodity prices including iron ore. Most sectors on the ASX closed higher, with financial, materials, and energy sectors registering the biggest gains. At the closing bell, the benchmark S&P/ASX 200 index inclined 41.90 points, or 0.79%, to 5,370.70, while the broader All Ordinaries index increased 37.70 points, or 0.7%, to 5,446.60.

Powered by Capital Market - Live News

G V Films to announce September quarter results
Nov 11,2016

G V Films announced that a meeting of the Board of Directors of the Company is scheduled to be held on 14 November 2016, inter alia, to transact the following;

- To consider and approve the Unaudited Financial Results of the Company for quarter ended 30 September 2016.

Powered by Capital Market - Live News

G V Films to announce September quarter results
Nov 11,2016

G V Films announced that a meeting of the Board of Directors of the Company is scheduled to be held on 14 November 2016, inter alia, to transact the following;

- To consider and approve the Unaudited Financial Results of the Company for quarter ended 30 September 2016.

Powered by Capital Market - Live News

Ipca Laboratories nudges up after posting stellar Q2 results
Nov 11,2016

The result was announced during market hours today, 11 November 2016.

Meanwhile, the S&P BSE Sensex was down 632.94 points or 2.3% at 26,884.74.

High volumes were witnessed on the counter. On BSE, so far 1.05 lakh shares were traded in the counter as against average daily volume of 34,209 shares in the past one quarter. The stock hit a high of Rs 618 and low of Rs 575 so far during the day. The stock had hit a 52-week high of Rs 888 on 19 August 2015. The stock had hit a 52-week low of Rs 402 on 6 June 2016. The stock underperformed the market over the past one month till 10 November 2016, declining 4.47% compared with 2.01% fall in the Sensex. The scrip however outperformed the market in past one quarter, gaining 17.96% as against Sensexs 0.93% fall.

The mid-cap company has equity capital of Rs 25.24 crore. Face value per share is Rs 2.

Ipca Laboratories earnings before interest, tax, depreciation and amortization (EBITDA) margin rose to 14.68% in Q2 September 2016 from 11.25% in Q2 September 2015. The companys Indian formulations income rose 23% to Rs 404.36 crore in Q2 September 2016 over Q2 September 2015. Exports income rose 10% to Rs 410.34 crore in Q2 September 2016 over Q2 September 2015.

Ipca Laboratories is vertically integrated and produces finished dosage forms and active pharmaceuticals ingredients.

Powered by Capital Market - Live News

Board of Noida Medicare Centre to consider September quarter results
Nov 11,2016

Noida Medicare Centre announced that the Board Meeting of the Company will be held on 14 November 2016, to consider and take on record Unaudited Financial Results for the quarter and six months ended on 30 September 2016.

Powered by Capital Market - Live News

Repro India appoints director
Nov 11,2016

Repro India announced that the Board of Directors of the Company in their meeting held on 11 November 2016, have appointed Ms. Bhumika Batra as an Additional Director (Non-Executive Independent Director) on the Board of the Company w.e.f. 11 November 2016.

Powered by Capital Market - Live News

Infosys announces investment in TidalScale
Nov 11,2016

Infosys announced that it has made an investment in TidalScale,a pioneer in Software-Defined Servers that simplify the way companies can apply computing resources to tackle big problems. The investment will be completed on or before 24 November 2016.

Powered by Capital Market - Live News

Board of Mahindra & Mahindra approves change in directorate
Nov 11,2016

Mahindra & Mahindra announced that the recommendation of the Governance, Nomination and Remuneration Committee, the Board of Directors of the Company at its Meeting held on 11 November 2016, has

1. Designated and appointed Anand Mahindra, who currently holds the position of Chairman and Managing Director, as Executive Chairman for a period of 5 (Five) years with effect from12 November 2016 upto and including 11 November 2021; subject to approval of the Shareholders;and

2. Appointed Pawan Goenka who currently holds the position of Executive Director and Group President (Auto and Farm Sector), as Managing Director for a period of 4 (Four) years from 12 November 2016 upto and including 11 November 2020; subject to approval of the Shareholders.

Powered by Capital Market - Live News

Mahindra & Mahindra appoints director
Nov 11,2016

Mahindra & Mahindra announced that the Board of Directors of the Company at its Meeting held on 11 November 2016, has approved the appointment of T. N. Manoharan, as an Additional Director of the Company who would be an Independent Director, with effect from 11 November 2016.

Powered by Capital Market - Live News

Alkem Lab declines as bottom line growth lags growth in top line in Q2
Nov 11,2016

The result was announced during market hours today, 11 November 2016.

Meanwhile, the S&P BSE Sensex was down 592.75 points or 2.15% at 26,924.93.

On BSE, so far 12,000 shares were traded in the counter as against average daily volume of 5,704 shares in the past two weeks. The stock hit a high of Rs 1,680 and a low of Rs 1,568.20 so far during the day. The stock had hit a record high of Rs 1,852.95 on 29 September 2016. The stock had hit a record low of Rs 1,175 on 2 May 2016.

The large-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.

The companys earnings before interest, taxation, depreciation and amortization (EBITDA) rose 21.5% to Rs 310.50 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin improved to 18.9% in Q2 September 2016, from 18.5% in Q2 September 2015.

Commenting on the companys performance, Prabhat Agrawal, CEO, Alkem, said the company has delivered a robust growth in its India business largely driven by strong execution of its market strategies. The companys international business too delivered a healthy growth during the quarter mainly driven by its US business, he said. Alkems ongoing efforts towards margin improvement also are yielding results as evident from year on year (YoY) improvement in its gross and EBITDA margins despite the regulatory price cuts, Agrawal said. Alkem looks forward to build on this momentum, he added.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News

Dr Reddys Laboratories launches Raloxifene Hydrochloride Tablets, 60 mg
Nov 11,2016

Dr Reddys Laboratories has launched Raloxifene Hydrochloride Tablets in 60 mg, a therapeutic equivalent of generic verion of Evista tablets in United States market, approved by USFDA. The tablets are available in bottle count sizes of 30,100 and 1000.

Powered by Capital Market - Live News

Navneet Education fixes record date for buyback of shares
Nov 11,2016

Navneet Education has fixed 25 November 2016 as the Record Date for the purpose of Buyback of Equity Shares.

Powered by Capital Market - Live News

APM Industries to pay interim dividend for FY 2017
Nov 11,2016

APM Industries announced that Interim Dividend @ Rs. 1.50 per equity share (i.e. 75%) on face value of Rs. 2.00/- per share for the Financial Year 2016-2017 will be paid on or after 28 November 2016.

Powered by Capital Market - Live News

Board of APM Industries declares interim dividend
Nov 11,2016

APM Industries announced that the Board in its meeting held on 11 November 2016 has declared an Interim Dividend @ Rs. 1.50 per equity share (i.e. 75%) on face value of Rs. 2.00/- per share for the Financial Year 2016-2017.

The payment of dividend will be made on or after 28 November 2016.

Powered by Capital Market - Live News